Possible effects of Phillyrea latifolia on weight loss in rats fed a high-energy diet

Pharm Biol. 2016 Oct;54(10):1991-7. doi: 10.3109/13880209.2015.1137952. Epub 2016 Feb 5.

Abstract

Context Phillyrea latifolia L. (Oleaceae), commonly found in the Mediterranean region in Turkey, is used as medicinal teas for weight loss and hyperglycaemia in folk medicine. Objective The study investigated the possible effects of P. latifolia leaves aqueous extract's on weight loss and biochemical-histological changes in the rats fed a high-energy diet (HED), also isolated and determined the main phenolic compounds. Materials and methods Twenty-four male Wistar albino rats were divided into four equal groups such as the HED group fed a HED, the PLE group given only the extract of P. latifolia leaves (220 mg/kg), the HED + PLE group administrated with the extract of leaves (220 mg/kg) after being fed with HED and a control group fed with standard pellet diet. Results PLE administration caused a remarkable decrement of body weight in the HED + PLE group (p < 0.05). PLE showed an improved effect on structural integrity and decreased leukocyte infiltration in liver and small intestinal tissues. The blood glucose (117.3 mmol/L), leptin (5.6 ng/mL), total cholesterol (61.8 mg/dL) and LDL (9.3 mmol/L) levels were significantly increased in the HED group. PLE administration in the HED group decreased these levels. The levels of HDL (26.8 mmol/L) in the HED + PLE group were higher than both control and HED groups. Chemical composition was investigated and luteolin 7-O-glucoside and chlorogenic acid were determined for the first time in Turkish sample from the EtOAc extract of leaves. Discussion and conclusion Phillyrea latifolia leaves may have beneficial effects on obesity related cellular problems and may become a good source of antidiabetic medication.

Keywords: High-density lipoprotein; leptin; liver; low-density lipoprotein; obesity; small intestine; total cholesterol.

MeSH terms

  • Animals
  • Anti-Obesity Agents / isolation & purification
  • Anti-Obesity Agents / pharmacology*
  • Biomarkers / blood
  • Blood Glucose / drug effects
  • Blood Glucose / metabolism
  • Chlorogenic Acid / isolation & purification
  • Chlorogenic Acid / pharmacology
  • Diet, High-Fat*
  • Disease Models, Animal
  • Energy Intake*
  • Glucosides / isolation & purification
  • Glucosides / pharmacology
  • Hypoglycemic Agents / isolation & purification
  • Hypoglycemic Agents / pharmacology
  • Intestine, Small / drug effects
  • Intestine, Small / pathology
  • Lipids / blood
  • Liver / drug effects
  • Liver / pathology
  • Luteolin / isolation & purification
  • Luteolin / pharmacology
  • Male
  • Obesity / blood
  • Obesity / etiology
  • Obesity / physiopathology
  • Obesity / prevention & control*
  • Oleaceae* / chemistry
  • Phytotherapy
  • Plant Extracts / isolation & purification
  • Plant Extracts / pharmacology*
  • Plant Leaves
  • Plants, Medicinal
  • Rats, Wistar
  • Time Factors
  • Weight Loss / drug effects*

Substances

  • Anti-Obesity Agents
  • Biomarkers
  • Blood Glucose
  • Glucosides
  • Hypoglycemic Agents
  • Lipids
  • Plant Extracts
  • Chlorogenic Acid
  • luteolin-7-glucoside
  • Luteolin